Nonrth America Scar Treatment Market
                     Nonrth America Scar Treatment Market - Size, Share, Outlook, and 
Opportunity Analysis, 2019 - 2027                                                                                                      
Healing of damaged tissues or wounds may create marks on the skin. These 
marks are referred as scars. Burn injury or other trauma condition, including 
surgery can also lead to a scar. Scars may be raised or recessed, different in 
color or texture from the surrounding healthy tissue, or particularly noticeable due
to their size, shape, or location. 
Request a sample copy of this report:- https://www.coherentmarketinsights.com/insight/request-
sample/3305 
Increasing incidents of burns is expected to boost growth of North America scar
treatment market over the forecast period. For instance, according to the Centers
for Disease Control and Prevention (CDC),Increasing number of accidents and
surgeries is also expected to boost growth of the market. For instance, according
to  2018  Fatal  Motor  Vehicle  Crashes:  Overview  by  National  Highway  Traffic
Safety Administration, a U.S. federal agency, 10,511 deaths were registered in
the U.S. in 2018.U.S. held dominant position in North America scar treatment
market  in  2018,  accounting  for  87.9% share  in  terms  of  value,  followed  by
Canada.
High cost of laser treatment is expected to hamper growth of North America scar
treatment  market  over  the  forecast  period.  For  instance,  according  to  the
American  Society  of  Plastic  Surgeons,  the  average  cost  for  laser  skin
resurfacing, which includes scar treatment, is US$ 2,071 for an ablative laser,
whereas the average price for non-ablative laser treatment is US$ 1,144.
Moreover,  scar  treatment  can  lead  to  several  side  effects,  which  are  also
expected hinder growth of the market. Side effects of ablative laser resurfacing
include  temporary  burning  discomfort,  oozing,  crusting,  ulceration,  erythema,
edema, acneiform eruptions, eczematous dermatitis, and infections. Side effects
of  non-ablative  laser  include transient  erythema,  blistering,  crusting,  scarring,
post-inflammatory hyperpigmentation, and post-treatment purpura lasting for up
to one week.Increasing demand for prescription products for scar treatment is
expected to offer lucrative growth opportunities for players in North America scar
treatment market.  Majority of  the populace in North America prefer to consult
qualified dermatologists and opt for prescribed products rather than using over-
the-counter cosmetic products for the treatment of scars.
Moreover, technological advancements in the treatment of organ scarring is also
expected to boost growth of the market. For instance, in December 2019, in the
journal Cell Reports, researchers from the University of California Los Angeles
reported development of accurate model of organ scarring using stem cells in a
labTopical sub segment in product type segment in North America scar treatment
market was valued at US$ 2,222.8 Mn in 2018 and is expected to reach US$
3,061.4 Mn by 2027 at a CAGR of 3.6% during the forecast period.
The  demand  for  silicon-based  products  is  increasing  in  the  market  for  scar
treatment. This is owing to the ability of these products to reduce the size and
darkness of  scars and protect  the wound from moisture and further infection.
Moreover,  silicone  gel  sheets  are  biocompatible  (with  extended  wear  time),
repositionable, resistant to microbial growth and hydrophobicity, and are effective
in treatment of burn scars, post-surgical scars, and wound scars.
The market is also witnessing increasing adoption of ablative laser resurfacing
(ALR)  and  non-ablative  fractional  lasers  (NAFL)  as  the  approach  can  offer
improvement in the pigmentation and thickness of surgical scars, atrophic scars,
hypertrophic scars, and hypopigmented scars. Moreover, use of ALR is effective
for the treatment of traumatic and surgical scars.
Major players operating in North America scar treatment market include, Smith &
Nephew Inc.,  Merz Inc.,  Enaltus LLC, Oculus Innovative Sciences,  Inc.,  CCA
Industries,  Cynosure,  Inc.,  Avita  Medical,  Lutronics,  Janssen  Biotech,  Inc.,
Luminus Inc., Syneron Medical Ltd., and NutraMarks, Inc.
Key players in the market are focused on product launch and assessment to
expand their  product  portfolio.  For  instance,  in  June 2019,  AVITA Medical,  a
regenerative  medicine  company,  announced  new  preliminary  RECELL
Autologous Cell Harvesting Device (RECELL System) data at the 24th annual
World Congress of Dermatology Meeting. The RECELL system is used in the
treatment of vitiligo and facial acne scars.
Get the main link:- https://www.coherentmarketinsights.com/market-insight/north-america-scar-
treatment-market-3305 
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
Visit our news Website: http://www.coherentchronicle.com/